Grail shares plunge after Galleri test misses primary endpoint
Title: Significant Market Impact Following Grail’s Galleri Test Failure Publication Date: February 20, 2026 Grail Inc., a pioneering company in the field of cancer detection, experienced a drastic stock market decline after the reported failure of its key Galleri multicancer…
